{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:34:58Z","timestamp":1786991698050,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jcjo.2020.01.015","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T09:16:56Z","timestamp":1584695816000},"page":"286-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents"],"prefix":"10.1016","volume":"55","author":[{"given":"Philip P.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2020.01.015_bib0001","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ophtha.2017.01.001","article-title":"Trends in vitreoretinal procedures for Medicare beneficiaries, 2000 to 2014","volume":"124","author":"McLaughlin","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0002","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":"Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials","volume":"127","author":"Bhavsar","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/IAE.0000000000000392","article-title":"Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon","volume":"35","author":"Bhavsar","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000329863","article-title":"Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor","volume":"226","author":"Inoue","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0005","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/eye.2012.199","article-title":"Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes","volume":"26","author":"Lyall","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0006","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0008","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2013.08.037","article-title":"The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection","volume":"121","author":"Storey","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bjophthalmol-2015-307707","article-title":"Incidence and clinical features of post-injection endophthalmitis according to diagnosis","volume":"100","author":"Rayess","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0011","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","article-title":"Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections","volume":"119","author":"Cheung","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0012","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","article-title":"Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center","volume":"31","author":"Moshfeghi","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0161-6420(97)30326-1","article-title":"The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum","volume":"104","author":"Johnson","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0014","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajo.2019.06.008","article-title":"Changes in management based on vitreous culture in endophthalmitis after intravitreal anti-vascular endothelial growth factor injection","volume":"207","author":"Patel","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/IAE.0000000000000694","article-title":"Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy","volume":"36","author":"Garg","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0016","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/IAE.0b013e318221594a","article-title":"Endophthalmitis after intravitreal injection: the importance of viridans streptococci","volume":"31","author":"Chen","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0017","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/IAE.0000000000001358","article-title":"Microbiologic spectrum and visual outcomes of acute-onset endophthalmitis undergoing therapeutic pars plana vitrectomy","volume":"37","author":"Sridhar","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0018","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","article-title":"Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask","volume":"251","author":"Shimada","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0019","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/IAE.0b013e3182877585","article-title":"Povidone-iodine contact time and lid speculum use during intravitreal injection","volume":"33","author":"Friedman","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0021","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.oret.2017.06.004","article-title":"Timing of povidone-iodine application to reduce the risk of endophthalmitis after intravitreal injections","volume":"2","author":"Levinson","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00417-015-3035-x","article-title":"The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection","volume":"254","author":"Storey","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jcp.29.8.752","article-title":"Absence of bacterial resistance to povidone iodine","volume":"29","author":"Houang","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2013.10.003","article-title":"Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics","author":"Hsu","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.87.2.163","article-title":"Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study","volume":"87","author":"Ferguson","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0026","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archopht.1984.01040030584025","article-title":"Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva","volume":"102","author":"Apt","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5301\/ejo.5000093","article-title":"Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery","volume":"22","author":"Nentwich","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0028","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajo.2007.04.011","article-title":"The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials","volume":"144","author":"Bhavsar","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajo.2010.08.044","article-title":"Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use","volume":"151","author":"Wykoff","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.07.010","article-title":"Endophthalmitis after intravitreal injections in patients with self-reported iodine allergy","volume":"170","author":"Modjtahedi","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0031","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(95)90106-X","article-title":"Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis","volume":"345","author":"Seal","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0032","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1097\/IAE.0000000000001800","article-title":"Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine","volume":"38","author":"Oakley","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0033","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.ophtha.2016.08.022","article-title":"Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature","volume":"123","author":"Merani","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0034","series-title":"Recent advances in the diagnosis and management of endophthalmitis","author":"Garg","year":"2019"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0035","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2009.02.024","article-title":"A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections","volume":"116","author":"Moss","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0036","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archophthalmol.2012.227","article-title":"Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics","volume":"130","author":"Bhavsar","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 12","key":"10.1016\/j.jcjo.2020.01.015_bib0037","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","article-title":"Intravitreal injection technique and monitoring: updated guidelines of an expert panel","volume":"34","author":"Avery","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0038","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0039","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archophthalmol.2011.213","article-title":"Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections","volume":"129","author":"Kim","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0040","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"Shah","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0041","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jcrs.2013.11.046","article-title":"Increase in microbial contamination risk with compression of the lid margin in eyes having cataract surgery","volume":"40","author":"Ye","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006353.pub3","article-title":"Use of plastic adhesive drapes during surgery for preventing surgical site infection","author":"Webster","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0043","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/OPTH.S24358","article-title":"Evaluation of patients\u2019 experiences at different stages of the intravitreal injection procedure \u2013 what can be improved?","volume":"5","author":"Tailor","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0044","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ajo.2007.01.035","article-title":"Tunneled scleral incision to prevent vitreal reflux after intravitreal injection","volume":"143","author":"Rodrigues","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00006982-200510000-00027","article-title":"Re: Evolving guidelines for intravitreous injections","volume":"25","author":"Garg","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0046","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/IAE.0b013e3181eac724","article-title":"Randomized trial of anesthetic methods for intravitreal injections","volume":"31","author":"Blaha","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0047","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/IAE.0b013e3181ef463d","article-title":"Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia","volume":"31","author":"Inman","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0048","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3928\/15428877-20120119-01","article-title":"Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection","volume":"43","author":"Lad","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0049","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jcrs.2008.05.056","article-title":"Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival","volume":"34","author":"Boden","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1517\/17425247.2014.909806","article-title":"Safety of bilateral intravitreal injections delivered in a teaching institution","volume":"11","author":"Chao","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.02.013","article-title":"Bilateral simultaneous intravitreal injections in the office setting","volume":"148","author":"Bakri","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.06.022","article-title":"Endophthalmitis rates after bilateral same-day intravitreal anti-vascular endothelial growth factor injections","volume":"194","author":"Borkar","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0053","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaophthalmol.2013.88","article-title":"An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone","volume":"131","author":"Sheyman","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0054","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/IAE.0000000000000071","article-title":"No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting","volume":"34","author":"Brynskov","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0055","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/bjophthalmol-2012-302030","article-title":"Intravitreal injections: is there benefit for a theatre setting?","volume":"96","author":"Abell","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/IAE.0000000000000008","article-title":"Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting","volume":"34","author":"Tabandeh","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0057","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","article-title":"Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies","volume":"31","author":"McCannel","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0058","first-page":"473","article-title":"Reducing oral flora contamination of intravitreal injections with face mask or silence","volume":"32","author":"Doshi","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0059","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archophthalmol.2011.227","article-title":"Bacterial dispersal associated with speech in the setting of intravitreous injections","volume":"129","author":"Wen","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0060","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3928\/23258160-20151027-07","article-title":"Effect of a strict \u2018no-talking\u2019 policy during intravitreal injection on post-injection endophthalmitis","volume":"46","author":"Garg","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0061","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2018.11.023","article-title":"The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab","volume":"199","author":"Storey","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0062","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2018.3939","article-title":"Association of acute endophthalmitis with intravitreal injections of corticosteroids or anti-vascular growth factor agents in a nationwide study in France","volume":"136","author":"Baudin","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0063","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/IAE.0000000000002351","article-title":"Comparative risk of endophthalmitis after intravitreal injection with bevacizumab, aflibercept, and ranibizumab","volume":"39","author":"Bavinger","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0064","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ophtha.2014.09.001","article-title":"Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencing","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2020.01.015_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1537-2995.2000.40020245.x","article-title":"Prevalence of the newly described human circovirus, TTV, in United States blood donors","volume":"40","author":"Handa","year":"2000","journal-title":"Transfusion"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418220300429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418220300429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:08:24Z","timestamp":1757794104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418220300429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0008418220300429"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2020.01.015","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2020.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}